BioMarin Pharmaceutical Inc. (LON:0HNC)
London
· Delayed Price · Currency is GBP · Price in USD 68.45
-0.47 (-0.69%)
At close: Feb 21, 2025
BioMarin Pharmaceutical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 942.84 | 755.13 | 724.53 | 587.28 | 649.16 | Upgrade
|
| Short-Term Investments | 194.86 | 318.68 | 567.01 | 426.6 | 416.23 | Upgrade
|
| Cash & Short-Term Investments | 1,138 | 1,074 | 1,292 | 1,014 | 1,065 | Upgrade
|
| Cash Growth | 5.95% | -16.86% | 27.39% | -4.83% | 41.33% | Upgrade
|
| Accounts Receivable | 660.54 | 633.7 | 461.32 | 373.4 | 448.35 | Upgrade
|
| Receivables | 660.54 | 633.7 | 461.32 | 373.4 | 448.35 | Upgrade
|
| Inventory | 1,233 | 1,107 | 894.08 | 776.67 | 698.55 | Upgrade
|
| Other Current Assets | 201.53 | 141.39 | 104.52 | 110.44 | 129.93 | Upgrade
|
| Total Current Assets | 3,232 | 2,956 | 2,751 | 2,274 | 2,342 | Upgrade
|
| Property, Plant & Equipment | 1,043 | 1,112 | 1,114 | 1,082 | 1,090 | Upgrade
|
| Long-Term Investments | 521.24 | 622.44 | 370.34 | 524.29 | 295.97 | Upgrade
|
| Goodwill | 196.2 | 196.2 | 196.2 | 196.2 | 196.2 | Upgrade
|
| Other Intangible Assets | 255.28 | 325.3 | 338.57 | 388.65 | 417.27 | Upgrade
|
| Long-Term Deferred Tax Assets | 1,489 | 1,546 | 1,505 | 1,450 | 1,432 | Upgrade
|
| Other Long-Term Assets | 251.39 | 83.56 | 98.78 | 89.2 | 74.63 | Upgrade
|
| Total Assets | 6,989 | 6,842 | 6,375 | 6,005 | 5,848 | Upgrade
|
| Accounts Payable | 606.99 | 315.51 | 231.24 | 199.68 | 191.43 | Upgrade
|
| Accrued Expenses | - | 311.55 | 293.53 | 267.65 | 257.27 | Upgrade
|
| Current Portion of Long-Term Debt | - | 493.88 | - | - | - | Upgrade
|
| Current Portion of Leases | - | 8.78 | 10.38 | 10.46 | 11.75 | Upgrade
|
| Current Income Taxes Payable | - | 2.65 | 16.21 | 1.21 | 9.66 | Upgrade
|
| Current Unearned Revenue | - | 4.62 | 0.71 | 6.96 | 0.15 | Upgrade
|
| Other Current Liabilities | - | 40.04 | 36.81 | 60.54 | 22.29 | Upgrade
|
| Total Current Liabilities | 606.99 | 1,177 | 588.88 | 546.5 | 492.55 | Upgrade
|
| Long-Term Debt | 595.14 | 593.1 | 1,083 | 1,079 | 1,075 | Upgrade
|
| Long-Term Leases | - | 38.12 | 26.51 | 33.84 | 44.49 | Upgrade
|
| Other Long-Term Liabilities | 128.82 | 81.81 | 73.5 | 79.69 | 129.84 | Upgrade
|
| Total Liabilities | 1,331 | 1,890 | 1,772 | 1,739 | 1,742 | Upgrade
|
| Common Stock | 0.19 | 0.19 | 0.19 | 0.18 | 0.18 | Upgrade
|
| Additional Paid-In Capital | 5,802 | 5,612 | 5,405 | 5,192 | 4,993 | Upgrade
|
| Retained Earnings | -194.7 | -621.55 | -789.2 | -930.76 | -861.61 | Upgrade
|
| Comprehensive Income & Other | 50.43 | -38.65 | -12.73 | 4.74 | -25.98 | Upgrade
|
| Shareholders' Equity | 5,658 | 4,952 | 4,603 | 4,266 | 4,106 | Upgrade
|
| Total Liabilities & Equity | 6,989 | 6,842 | 6,375 | 6,005 | 5,848 | Upgrade
|
| Total Debt | 595.14 | 1,134 | 1,120 | 1,123 | 1,131 | Upgrade
|
| Net Cash (Debt) | 542.57 | -60.07 | 171.63 | -109.51 | -66 | Upgrade
|
| Net Cash Per Share | 2.76 | -0.31 | 0.91 | -0.60 | -0.34 | Upgrade
|
| Filing Date Shares Outstanding | 190.76 | 188.68 | 186.53 | 184.03 | 181.83 | Upgrade
|
| Total Common Shares Outstanding | 190.76 | 188.6 | 186.25 | 183.91 | 181.74 | Upgrade
|
| Working Capital | 2,625 | 1,779 | 2,163 | 1,728 | 1,850 | Upgrade
|
| Book Value Per Share | 29.66 | 26.25 | 24.71 | 23.19 | 22.59 | Upgrade
|
| Tangible Book Value | 5,207 | 4,430 | 4,068 | 3,681 | 3,493 | Upgrade
|
| Tangible Book Value Per Share | 27.29 | 23.49 | 21.84 | 20.01 | 19.22 | Upgrade
|
| Land | - | 90.78 | 90.79 | 90.42 | 90.42 | Upgrade
|
| Buildings | - | 860.81 | 819.1 | 774.92 | 761.56 | Upgrade
|
| Machinery | - | 796.61 | 736.25 | 688.54 | 644.4 | Upgrade
|
| Construction In Progress | - | 100.01 | 143.38 | 136.74 | 109.14 | Upgrade
|
| Leasehold Improvements | - | 58.23 | 59.53 | 55.28 | 55.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.